000 01397 a2200361 4500
005 20250515162507.0
264 0 _c20090512
008 200905s 0 0 eng d
022 _a1871-5303
024 7 _a10.2174/187153009787582414
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLing, Shanhong
245 0 0 _aCardiovascular physiology of androgens and androgen testosterone therapy in postmenopausal women.
_h[electronic resource]
260 _bEndocrine, metabolic & immune disorders drug targets
_cMar 2009
300 _a29-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAndrogens
_xphysiology
650 0 4 _aAnimals
650 0 4 _aAtherosclerosis
_xchemically induced
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCardiovascular System
_xdrug effects
650 0 4 _aEndothelial Cells
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMacrophages
_xdrug effects
650 0 4 _aMetabolic Syndrome
_xchemically induced
650 0 4 _aPostmenopause
_xphysiology
650 0 4 _aTestosterone
_xtherapeutic use
700 1 _aKomesaroff, Paul A
700 1 _aSudhir, Krishnankutty
773 0 _tEndocrine, metabolic & immune disorders drug targets
_gvol. 9
_gno. 1
_gp. 29-37
856 4 0 _uhttps://doi.org/10.2174/187153009787582414
_zAvailable from publisher's website
999 _c18715461
_d18715461